At Pipeline Day, Pfizer forecasts annual revenue from its mRNA vaccine portfolio could reach $10-$15 billion by 2030. Last month in its Q3 earnings release, Pfizer raised its forecast for 2022 sales of its vaccine by $2 billion to $34 billion. Find out more on benzinga.com, link in bio. Follow benzinga . . . . . . . . #money #earnings #business #stocktrading #entrepreneur #investing #success #trading #pfizer #stockmarket #stockmarketinvesting #financefreedom #investing101 #moneymoves #wealth #wallstreet #success #stockstowatch #economy #tradingstrategy #news